Publication

Article

BioPharm International

BioPharm International-05-15-2017
Volume2017 eBook
Issue 1
Pages: s16-s18

Quality Metrics and CMO Agreement

FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.

As Naheed Sayeed, Ajay Pazhayattil and Jena Spes of Apotex write, FDA’s guidances on quality agreements and quality metrics came at just the right time to address ongoing issues.  Both guidances should benefit the industry, but, above all, the consumer, by establishing a framework for developing a culture of quality.

 

Download BioPharm International's

2017 Outsourcing Resources eBook

.

 

 

 

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
© 2025 MJH Life Sciences

All rights reserved.